Global Demand for Capsule Endoscope Systems Is Predicted to Increase at a High-Value CAGR of 8.3% by 2027

The global capsule endoscope systems market currently accounts for a valuation of US$ 465 million and is expected to reach US$ 695 million by the end of 2027. This is because global demand for capsule endoscope systems is predicted to increase at a high-value CAGR of 8.3% from 2022 to 2027.

Download Free Sample Copy of This Report:

https://www.factmr.com/connectus/sample?flag=S&rep_id=7653

Sales of small bowel capsules are expected to rise at a CAGR of 8% over the forecast period. Growing usage of small bowel capsules by medical and healthcare professionals for speedier and more precise diagnosis of chronic diseases is driving market demand considerably.

Capsule endoscope systems are becoming more important for accurately diagnosing gastrointestinal disorders

Capsule endoscopy is a relatively new technology that is revolutionizing the diagnosis of gastrointestinal disorders. This technology involves the use of a small capsule containing a tiny camera that is swallowed by the patient. The capsule travels through the digestive tract, taking pictures along the way, which are then transmitted to a receiver worn by the patient.

The images are then analyzed by a physician to diagnose and monitor various gastrointestinal disorders. This technology has been found to be more accurate than traditional endoscopy for diagnosing certain conditions, such as Crohn's disease, ulcerative colitis, and small bowel tumors. It also allows for earlier detection of problems, which can lead to better outcomes for patients.

Share Your Requirements & Get Customized Reports:

https://www.factmr.com/connectus/sample?flag=RC&rep_id=7653

Competitive Landscape

Key companies are focusing on broadening their product lines and growing their market share. The increased demand for capsule-based endoscopes and endoscopic systems for different screening and diagnostic procedures has created intense competition among the existing providers. Furthermore, the competition is getting more intense due to technological advancements in the field of endoscopy made by key players.

For instance :

• In 2021, the ENDO-AID product, developed by Olympus Corporation, enabled the real-time presentation of automatically discovered worrisome lesions. The EVIS X1, Olympus' most advanced endoscopic system to date, and ENDO-AID, are compatible.

Key Companies Profiled:

• Boston Scientific Corporation
• CapsoVision, Inc.
• Interscope, Inc.
• Medtronic PLC
• Olympus Corporation
• RF System lab
• IntroMedic Co.
• MEDTRONIC PLC.
• Fujifilm Holding Corporation
• Check Cap

Full Access to this Report Is Available:

https://www.factmr.com/checkout/7653

Key Segments:

• By Product :

o Small Bowel Capsules
o Esophageal Capsules
o Colon Capsules

• By Application :

o OGIB (Obscure Gastrointestinal Bleeding)
o Crohn's Disease
o Small Intestine Tumor
o Others

• By End User :

o Hospitals
o Ambulatory Surgery Centers
o Others

• By Region :

o North America
o Europe
o Asia Pacific
o Latin America
o Middle East & Africa

Questionnaire answered in the report include:

• How the industry has grown?
• What is the present and future outlook on the basis of region?
• What are the challenges and opportunities?
• Why the consumption in region?
• In which year segment is expected to overtake segment?

Explore Fact.MR's More Insights on the Healthcare Domain

Skincare Device Market: https://www.prnewswire.com/news-releases/sales-of-skincare-devices-to-surpass-uss-43-48-bn-as-prevalence-of-dermatological-diseases-increases-factmr-report-301506974.html

ENT Medical Devices Market: https://www.prnewswire.com/news-releases/ear-nose-throat-ent-medical-devices-manufacturers-target-applications-in-cataract--glaucoma-treatment-factmr-301262063.html

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of industry research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.